CDER New August 11, 2015

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

August 10, 2015


New and Generic Drug Approvals

August 8, 2015

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Synarel nafarelin acetate Spray, Metered;Nasal Gd Searle Llc Labeling Revision

 August 7, 2015

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Anoro Ellipta umeclidinium bromide; vilanterol trifenatate Powder;Inhalation Glaxosmithkline Manufacturing Change or Addition
Daranide dichlorphenamide Tablet;Oral Taro Efficacy Supplement with Clinical Data to Support
Furosemide furosemide Tablet;Oral Ivax Sub Teva Pharms Manufacturing Change or Addition
Imodium Multi-Symptom Relief loperamide hydrochloride; simethicone Tablet;Oral Mcneil Cons Manufacturing Change or Addition
Nymalize nimodipine Solution;Oral Arbor Pharms Llc Manufacturing Change or Addition
Omeprazole omeprazole Tablet, Delayed Release;Oral Dexcel Pharma Manufacturing Change or Addition
Priftin rifapentine Tablet;Oral Sanofi Aventis Us Manufacturing Change or Addition
Symlin pramlintide acetate Injectable;Subcutaneous Astrazeneca Ab Supplement
Technetium Tc 99m Generator technetium tc-99m sodium pertechnetate generator Solution;Intravenous, Oral Ge Healthcare Labeling Revision
Xenical orlistat Capsule;Oral Hoffmann La Roche Labeling Revision
Zipsor diclofenac potassium Capsule;Oral Depomed Inc Manufacturing Change or Addition

 


This email was sent to rssproject471@gmail.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery

Postingan terkait:

Belum ada tanggapan untuk "CDER New August 11, 2015"

Post a Comment